Demystifying the Relationship Between GLP-1s and Cancer

Complete transcript coming soon.

GLP-1s are among the most talked-about drugs on the market right now. But what do we actually know about how they relate to cancer risk? Join endocrinologist Dr. Josh Levine for a clear, evidence-based conversation that cuts through the noise, explaining what the current research does and doesn’t tell us, and helping you understand what these findings may mean for you.

Thank you to our webinar sponsor: Cooperative Agreement 24-0061 from the Centers for Disease Control and Prevention.